Contact Us  · Add to Favorite
Investor Relations Home
HomeInvestor Relations >  Investor Relations Home

Profile

China Nuokang Bio-Pharmaceutical Inc. is a leading, fully integrated, profitable biopharmaceutical company focused on researching, developing, manufacturing and marketing hematological and cardiovascular products. We sell a portfolio of fourteen products, which includes principal products Baquting®, a flagship hemocoagulase, and Aiduo®, a cardiovascular stress imaging agent. Our product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascula...

More »

More »Recent News

Date Title  
05/10/12 China Nuokang Bio-Pharmaceutical Inc. to Report First Quarter 2012 Financial Results Add to Briefcase
05/09/12 China Nuokang Bio-Pharmaceutical Inc. Announces Receipt of "Going Private" Proposal Add to Briefcase
03/14/12 China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results Add to Briefcase
02/27/12 China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2011 Financial Results Add to Briefcase
02/27/12 China Nuokang Bio-Pharmaceutical Inc. Provides Update on Continued Restructuring Efforts Add to Briefcase
Stock Information
NKBP (Common Stock)
Exchange NASDAQ (US Dollar)
Price $4.52
Change (%) Stock is Up 0.04 (0.86%)
Volume 77,500
Data as of 05/18/12 3:16 PM ET
Minimum 20 minutes delay

Refresh quote
Investor Tools
Print Print Page
E-mail E-mail Page
Briefcase Shareholder Briefcase
Download Center Download Library
RSS RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts
Financial Tear Sheet Financial Tear Sheet
ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516

Ms. Wen Lei Zheng:
Tel: (+86) 10-6583-7510

U.S. Tel: (646) 405-5180

Nuokang's Consultant Team
Steven Duan
Tel: +86-24-24696037
COPYRIGHT © 2012 ALL RIGHTS RESERVED BY NUOKANG MEDICINE
Address : No.18, Nanpingdong Road, Hunnan District, Shenyang Liaoning Province, China